During the past decade, Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 7 clinical trials were completed, i.e. on average, 53.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 6 trials as a collaborator, "Food and Drug Administration (FDA)" with 3 trials as a collaborator, "National Institutes of Health (NIH)" with 3 trials as a collaborator and "National Center for Research Resources (NCRR)" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania" are "Smoking Cessation" (5 trials), "Nicotine Addiction" (4 trials), "Smoking" (4 trials), "Smoking Behaviors" (2 trials) and "Weight Loss" (2 trials). Many other conditions were trialed in "Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania" in a lesser frequency.

Most popular intervention types in "Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania" are "Drug" (9 trials), "Other" (7 trials) and "Behavioral" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "BAS+" (2 trials), "Galantamine" (2 trials), "SC" (2 trials) and "2-[18F]-fluro-3-[2(S)-2-azethidinylmethoxy]-pyridine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".